Pfizer begins study of Covid jabs updated to match Omicron variant

25 January 2022, 14:54

Coronavirus – Thu Dec 2, 2021
Coronavirus – Thu Dec 2, 2021. Picture: PA

The new US study is enrolling up to 1,420 healthy adults.

Pfizer has begun a study comparing its original Covid-19 vaccine with doses specially tweaked to match the hugely contagious Omicron variant.

Pfizer and its partner BioNTech announced the study on Tuesday.

Vaccine makers have been updating their jabs to better match Omicron in case global health authorities decide the change is needed.

While Omicron is more likely than previous variants to cause infection even in people who have been vaccinated, it is not yet clear that a change to the vaccine recipe is needed.

The original jabs still offer good protection against severe illness and death. Studies in the US and elsewhere have made clear that adding a booster dose strengthens that protection and improves the chances of avoiding a milder infection.

“We recognise the need to be prepared in the event this protection wanes over time and to potentially help address Omicron and new variants in the future,” said Kathrin Jansen, Pfizer’s vaccine research chief.

The new US study is enrolling up to 1,420 healthy adults, aged 18 to 55, to test the updated jabs for use as a booster or for primary vaccinations.

HEALTH Coronavirus
(PA Graphics)

Researchers will examine the tweaked vaccine’s safety and how it revs up the immune system in comparison to the original jabs.

Full study results will take many months as volunteers receive multiple vaccine doses — and as researchers measure how long virus-fighting antibodies remain at high levels after an Omicron-adapted dose versus the regular booster.

Pfizer’s chief executive told CNBC earlier this month that the company could have some Omicron-matched doses ready as early as March, but doing what the company calls “at-risk” manufacturing does not mean those doses will be rolled out to the public.

Pfizer and other vaccine makers also have brewed and tested experimental doses to match previous variants, changes that ultimately were not needed but offered practice in tweaking the recipe.

In one study group, about 600 volunteers who received two doses of the current Pfizer vaccine three to six months ago will receive either one or two Omicron-based jabs as boosters.

Another 600 who have already had three regular doses of the Pfizer vaccine will be given a fourth dose of either the regular vaccine or the Omicron-matched version.

The study also will enrol some unvaccinated volunteers who will receive three doses of the Omicron-based vaccine.

By Press Association

Latest World News

See more Latest World News

A mountain range near Pokhara, Nepal

Plane with 22 on board missing in Nepal’s mountains

Pope Francis delivers a prayer from a window overlooking St Peter's Square

Pope names 21 new cardinals

Protesters clash with security forces in Khartoum

UN envoy decries Sudan violence after two killed in protests

Russia Ukraine War

Russian troops storm city amid eastern Ukraine bombardments

Meghan Markle is thought to have reached out to her estranged father

Meghan Markle 'has reached out to father' days after he suffered stroke and lost speech

Young Jewish people wave Israeli flags near the Western Wall in Jerusalem

Visit to holy site by far-right Israeli politician sparks Jerusalem unrest

Shoppers in a reopened mall in Beijing

Beijing and Shanghai ease Covid restrictions as outbreaks fade

Presidential candidate Gustavo Petro

Colombians to vote for president amid widespread discontent

Rescuers look out of the windows of a helicopter

25 missing after cargo boat sinks in Indonesia

Nigeria Church Stampede

31 dead in church fair stampede in Nigeria

Russia Ukraine War

Russia takes small cities as it aims to widen battle in east Ukraine

Iran accused of piracy for seizing two Greek oil tankers

Fears oil price will rise again after Iran accused of piracy for seizing Greek oil tankers

Building Collapse-Florida

Judge in US gives initial OK to a billion-dollar deal in Florida condo collapse

Cardinal Angelo Sodano

Powerful Vatican prelate Cardinal Angelo Sodano dies aged 94

Donald Trump

Senior Republicans’ claims at NRA rally called into question

Iranian collapse

Iranian police disperse crowd gathered at collapsed building